More Psilocybin Research

Studies over the past several years have shown promise in using psilocybin-assisted therapy to treat psychiatric disorders like depression.

A recent follow-up study by Johns Hopkins Medicine researchers found two doses of the hallucinogenic compound coupled with psychotherapy resulted in large decreases in major depressive disorder symptoms for most of the study’s participants.

New research is hinting at how the hallucinogenic compound may facilitate reduced depression symptoms.

Read more

Researching Psychedelics- It's Complicated

Researchers from SUNY Downstate Health Sciences University and McGill University published a paper in the journal Science Advances proposing a unique method for better understanding the interaction between hallucinogenic drugs, people’s brains, and different types of psychedelic experiences.

They did this by using artificial intelligence to look at real-life accounts of psychedelic experiences and compare them to how human brain chemistry engages with drugs on a molecular level.

However, while the researchers’ methods and goals push the envelope forward on understanding how psychedelics can help or harm individuals, the data they use could be unreliable.

Read more